In late 2008, a startup called Moksha8 convinced Pfizer (PFE) to do an unusual deal in Brazil. In exchange for a cut of sales, Moksha8 would promote a decades-old antibiotic called Vibramycin, along with several other brands in Pfizer’s portfolio of older drugs no longer protected by patents. Forecasting declining sales against competition from lower- [...]
-
Recent Posts
- Moksha8 Finds New Life for Old Drugs in Latin America
- Livescribe’s Jim Marggraff Pushes a Pen-Based Computing Revival
- Gibson Guitar Raid by U.S. Fires Up Tea Party, Charlie Daniels
- SoundOut Predicts Music Hits With Reviews, Linguistic Analysis
- Bandcamp Powers Online Sales, Aims to Fill Myspace ‘Vacuum’
Recent Comments
Archives
Categories
Meta